Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study.
CBD-rich cannabis calmed severe behavior in most kids with autism, yet parent-training programs already do the same without side-effects.
01Research in Context
What this study did
Doctors looked back at charts of 60 children with autism and severe behavior problems. All kids had taken cannabis oil rich in CBD for at least a month. Staff rated each child’s behavior outbreaks before and after the oil.
What they found
Six out of ten children were rated “much” or “very much” better. Parents and doctors noticed fewer meltdowns and calmer days. The team says a real controlled trial is now worth doing.
How this fits with other research
Burrell et al. (2025) show parent training also cuts disruptive behavior in autism. Their meta-analysis gives the same target—behavior outbreaks—but uses coaching instead of cannabis. Bearss et al. (2013) ran a small parent-training case series like this one and saw a 54 % drop in irritability. The CBD data line up: both approaches calm kids, one with pills, one with skills. No clash exists; the tools simply differ.
Why it matters
You now have two parent-friendly paths for severe behavior. If families want a drug-free route, start parent training—its evidence is stronger. If behavior is dangerous and meds are on the table, CBD oil looks hopeful but still needs trials. Track baseline meltdowns for two weeks before any change so you can spot real gains.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Start a two-week baseline count of meltdowns before recommending any new intervention.
02At a glance
03Original abstract
Anecdotal evidence of successful cannabis treatment in autism spectrum disorder (ASD) are accumulating but clinical studies are lacking. This retrospective study assessed tolerability and efficacy of cannabidiol-rich cannabis, in 60 children with ASD and severe behavioral problems (age = 11.8 ± 3.5, range 5.0-17.5; 77% low functioning; 83% boys). Efficacy was assessed using the Caregiver Global Impression of Change scale. Adverse events included sleep disturbances (14%) irritability (9%) and loss of appetite (9%). One girl who used higher tetrahydrocannabinol had a transient serious psychotic event which required treatment with an antipsychotic. Following the cannabis treatment, behavioral outbreaks were much improved or very much improved in 61% of patients. This preliminary study supports feasibility of CBD-based cannabis trials in children with ASD.
Journal of autism and developmental disorders, 2019 · doi:10.1007/s10803-018-3808-2